Damora Therapeutics, Inc.
DMRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001800315
In the last 90 days, Damora Therapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Damora Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 27 | 22 | −5 |
| Shares | 10.2M | 5.45M | −4.75M (−46.6%) |
| Value | $25.7M | $3.92M | −$21.8M (−84.7%) |
New holders (4)
Institutions that held Damora Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 17,307 | $12.5K | 0.00% |
| UBS Group AG | 7,088 | $5.10K | 0.00% |
| Spire Wealth Management | 1,999 | $1.44K | 0.00% |
| Morgan Stanley | 1 | $1 | 0.00% |
Sold out (9)
Institutions that held Damora Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cormorant Asset Management, LP | 1,020,238 | $2.57M |
| MAI Capital Management | 245,281 | $618.1K |
| Federated Hermes, Inc. | 100,000 | $252.0K |
| Susquehanna International Group, LLP | 95,936 | $241.8K |
| Two Sigma Advisers, LP | 48,900 | $123.2K |
| Trust Co of Toledo NA | 22,432 | $56.5K |
| Belvedere Trading LLC | 15,037 | $37.9K |
| Two Sigma Investments, LP | 12,731 | $32.1K |
| Citadel Advisors LLC | 2,237 | $5.64K |